Check out your Company Bowl for anonymous work chats.
UCHealth deploys BioIntelliSense BioButton™ Vaccine Monitoring Solution to health care workers receiving COVID-19 vaccine
BioIntelliSense and the American College of Cardiology Join Forces to Advance Remote Cardiac Care and to Offer the BioButton COVID-19 Screening Solution at ACC.21
BioIntelliSense BioButton™ Named CES 2021 Best of Innovation Award Honoree
Philips and BioIntelliSense form strategic collaboration to enhance remote patient monitoring for at-risk patients from the hospital into the home
BioIntelliSense Introduces the BioButton™ for 90-days of Continuous Wireless Temperature and Vital Signs Monitoring on a Coin-Sized Disposable Medical Device
BioIntelliSense Introduces the 5G-enabled BioHub Connectivity Gateway to Its Remote Patient Monitoring (RPM) Data Service
BioIntelliSense Expands Its Medical-Grade Data Services for Remote Care With First-of-Its-Kind Symptomatic Events and Biometric Monitoring
BioIntelliSense Announces FDA Clearance of the BioSticker™, the First Single-Use Medical Device Enabling 30 Days of Continuous Vital Signs Monitoring
The BioButton™ system is a scalable and cost-effective solution for COVID-19 symptom monitoring at school, home and work: FDA-cleared medical-grade wearable for continuous vital sign monitoring for up to 90-days Discreet, coin-sized, single-use disposable design for an effortless user experience Continuous temperature, respiratory rate and heart rate at rest measurements BioMobile™ daily health screening surveys based on CDC guidelines Efficient, non-location based contact tracing capability and reporting Health data protection through strict privacy and security safeguards
BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM) and Screening (COVID-19/Infection). Our medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics and symptomatic events through an effortless patient experience. The FDA-cleared BioSticker™ and BioButton™ devices make remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians, patients, and employers will now have access to high-resolution patient trending and reporting to enable medical grade care at home, and medical grade screening in the office, school, or residence. For more information on how BioIntelliSense is redefining remote patient monitoring through medical-grade and cost-effective data services, please contact us at info@biointellisense.com or visit our website at BioIntelliSense.com.
